|
Autoantibody Profiling for Serological Detection of Head and Neck Cancer
|
1R43CA139806-01
|
$217,801
|
$174,241
|
Khattar, Nada
|
20/20 GENESYSTEMS, INC.
|
|
Identification and Classification of Epigenetic Changes in Head and Neck Cancer
|
1R21CA131648-01A2
|
$219,120
|
$219,120
|
BELBIN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Genetic analysis of the P13K/Akt pathway in thyroid benign and malignant disease
|
1R01CA128943-01A2
|
$344,450
|
$344,450
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
$314,179
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Proteomic analysis of head & neck squamous cell cancer
|
5R33CA103547-05
|
$695,192
|
$695,192
|
PRYSTOWSKY, MICHAEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Role of Skp2-cyclin A Interaction in Normal Physiology and Cancer
|
1R01CA131421-01A2
|
$310,005
|
$155,003
|
ZHU, LIANG
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Bifunctional T cell receptor based immunotherapeutics
|
2R44CA097550-05A1
|
$1,000,000
|
$250,000
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
Radiation Therapy Oncology Group
|
2U10CA021661-33
|
$12,534,580
|
$3,258,991
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S1
|
$26,578
|
$3,455
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-22
|
$1,683,081
|
$218,801
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
5U24CA114734-05
|
$808,869
|
$80,887
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$444,820
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Influence of Mint Flavorings and pH on Nicotine Absorption in Smokeless Tobacco
|
1R21CA141639-01
|
$182,736
|
$182,736
|
Pickworth, Wallace
|
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$5,212
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Understanding the Roles of REGgamma in Anaplastic Thyroid Cancer Progression
|
5R01CA131914-02
|
$233,704
|
$233,704
|
LI, XIAOTAO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$4,310
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
$2,617
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients
|
5R01CA120950-03
|
$541,584
|
$541,584
|
LANGMORE, SUSAN
|
BOSTON MEDICAL CENTER
|
|
Pathogenesis of Epstein-Barr Virus Infection
|
5R01CA068051-14
|
$417,501
|
$41,750
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Patterns of Somatic Gene Alterations in Oral Cancer
|
2R01CA100679-06A1
|
$322,585
|
$322,585
|
Kelsey, Karl
|
BROWN UNIVERSITY
|
|
The Boston Collaborative Oral Cancer Study
|
5R01CA078609-10
|
$393,709
|
$374,024
|
Kelsey, Karl
|
BROWN UNIVERSITY
|
|
#258 Preventing Adverse Effects of Radiotherapy with CBLB502
|
N43CO900028-000
|
$149,987
|
$50,996
|
Krivokrysenko, Vadim
|
Buffalo BioLabs, LLC
|
|
"Curaxins, Multifunctional Anticancer Agents" - Topic 255
|
N43CO900064-000
|
$148,725
|
$74,363
|
Burkhart, Catherine
|
BUFFALO BIOLABS, LLC:1166747
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
$8,347
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-23
|
$1,282,700
|
$12,827
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
1K05CA136967-01A1
|
$131,592
|
$6,580
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Columbus Community Clinical Oncology Program
|
5U10CA035261-26
|
$930,000
|
$9,300
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
Commercialization of Magnetic Nanobeads for Cancer Cell Enrichment
|
5R42CA116048-04
|
$307,045
|
$153,523
|
Rampersaud, Arfaan
|
COLUMBUS NANOWORKS, INC.
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$116,889
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Signaling Pathways in Proliferation and Differentiation
|
5R01CA065842-15
|
$423,810
|
$423,810
|
EWEN, MARK
|
DANA-FARBER CANCER INSTITUTE
|
|
ECOG Statistical Office
|
5U10CA023318-33
|
$2,407,336
|
$48,147
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
EBV-Specific T-Cell Therapy for Nasopharynx Cancer: Immunomodulation and Response
|
5R21CA132279-02
|
$370,980
|
$370,980
|
POSNER, MARSHALL
|
DANA-FARBER CANCER INSTITUTE
|
|
Program Evaluation - Extramural Support
|
ExtraSupport209 [E]
|
$118,090,000
|
$496,000
|
N/A
|
Department of Health and Human Services
|
|
Eastern Cooperative Oncology Group Chair's Office
|
5U10CA086802-11
|
$655,420
|
$13,108
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Heat and Radiation Effects on Tumor Microcirculation
|
2R01CA040355-25
|
$355,193
|
$88,798
|
DEWHIRST, MARK
|
DUKE UNIVERSITY
|
|
Accurate, High Resolution 3D Dosimetry
|
5R01CA100835-06
|
$287,346
|
$143,673
|
OLDHAM, MARK
|
DUKE UNIVERSITY
|
|
Early Detection of Cancer By Affinity Mass Spectrometry
|
3U01CA085067-10S1
|
$409,141
|
$135,017
|
SEMMES, OLIVER
|
EASTERN VIRGINIA MEDICAL SCHOOL
|
|
Identifying High Risk Cells in Primary SCCHN to Predict Lymph Node Metastasis
|
5R21CA125062-02
|
$209,250
|
$209,250
|
CHEN, ZHUO
|
EMORY UNIVERSITY
|
|
Emory Molecular and Translational Imaging Center
|
5P50CA128301-02
|
$1,500,000
|
$270,000
|
Meltzer, Carolyn
|
EMORY UNIVERSITY
|
|
Emory-GA Tech Nanotechnology Center for Personalized an*
|
5U54CA119338-05
|
$3,691,806
|
$258,426
|
NIE, SHUMING
|
EMORY UNIVERSITY
|
|
SPORE in Head and Neck Cancer
|
3P50CA128613-03S1
|
$200,000
|
$200,000
|
SHIN, DONG
|
EMORY UNIVERSITY
|
|
SPORE in Head and Neck Cancer
|
5P50CA128613-03
|
$1,423,429
|
$1,423,429
|
SHIN, DONG
|
EMORY UNIVERSITY
|
|
Second Primary Tumor Prevention w/EGFR TKIs, COX-2 inhibitors Head & Neck Cancer
|
5R01CA112643-04
|
$328,776
|
$328,776
|
SHIN, DONG
|
EMORY UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-39
|
$809,323
|
$8,093
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
North Shore CCOP
|
5U10CA035279-26
|
$350,000
|
$3,500
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Eastern Cooperative Oncology Group
|
5U10CA027525-31
|
$453,259
|
$9,065
|
GOLDSTEIN, LORI
|
FOX CHASE CANCER CENTER
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE
|
5U10CA021115-35
|
$9,256,982
|
$185,140
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
Total relevant funding to Head and Neck for this search: $77,051,155
|